Drug Patents owned by Clarus

1. List of Jatenzo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US11179402 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Apr, 2026

(3 years from now)

US10617696 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11331325 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Jan, 2027

(3 years from now)

US8241664 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Mar, 2029

(6 years from now)

US8778916 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(7 years from now)

US11426416 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(7 years from now)

US10543219 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(7 years from now)

US11179403 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(7 years from now)

US8492369 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Dec, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Mar 27, 2022

Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient

Market Authorisation Date: 27 March, 2019

Treatment: Method of treating testosterone deficiency; A method of treating testosterone deficiency in men

Dosage: CAPSULE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in